Proximie announced today that it raised $80 million in a Series C financing round to support its health technology platform.
London-based Proximie earmarked the funds to accelerate the development of key products and services, build out its marketplace ecosystem and scale its centralized platform for connected surgical care in the operating room (OR).
According to a news release, Advent Life Sciences led the funding round with participation from new investors Emerson Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala Investment Company and the Minderoo Foundation.
Existing investors F-Prime Capital, Eight Roads, Questa Capital, Global Ventures and Maverick Ventures also participated in the Series C round.
Proximie’s operating system of the OR provides hospitals and surgical centers access to preoperative data that can help inform patient care, real-time collaborative tools to record, train and deliver care. It also offers postoperative content management tools to capture and distribute content to colleagues.
The company’s aim is to allow health systems to establish an intelligent, digital layer to the OR to enable them to save time, money and lives.
Proximie’s platform has been used for cases in surgical specialities across more than 500 hospitals worldwide, driving efficiencies in surgical backlog following COVID-19, increasing the speed of training surgeons while maintaining costs and building hub and spoke models centered on surgical care and expertise in central locations to reduce the time and costs associated with travel.
“Our vision is to democratize surgery through better data by connecting every OR and Cath Lab in the world,” Hachach-Haram said in the news release. “We began this journey enabling surgeons to virtually join any OR. Now, we’re using this capability to digitize the operating room, bringing patients the collective expertise of the best surgeons in the world – where data collected and shared on Proximie can help them receive life-saving care, no matter where they live.”